Showing results (291-300 of 320) with videos related to
Sort By:
Pageof 32
The Journal of Experimental Medicine|February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopesE Jäger, Y T Chen, J W Drijfhout, et al.Proceedings of the National Academy of Sciences of the United States of America|December 20, 1994
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinantsK Kitamura, E Stockert, P Garin-Chesa, et al.Cancer Immunity|May 16, 2003
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expressionM J Scanlan, I Gout, C M Gordon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, A M Scott, C R Divgi, et al.International Journal of Cancer|October 15, 1982
Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cellsP O Livingston, T Watanabe, H Shiku, et al.Blood|April 1, 1994
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicityP C Caron, J G Jurcic, A M Scott, et al.Cancer Research|June 19, 2001
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor gradeT Kurashige, Y Noguchi, T Saika, et al.British Journal of Clinical Pharmacology|March 22, 2001
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patientsP Tanswell, P Garin-Chesa, W J Rettig, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTLJ L Chen, P R Dunbar, U Gileadi, et al.Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigenT Ono, T Kurashige, N Harada, et al.Pageof 32